Diabetics are more likely to be
resistant to aspirin than the general
population, and higher doses are
associated with higher resistance
according to a study presented to
the 73rd Scientific Sessions of the
American Diabetes Association.
Scott Simpson from the University
of Alberta presented the meta-analysis
of 31 studies.
Other analyses have shown that
aspirin resistance is associated
with a higher risk of adverse
cardiovascular events.The above article was sent to subscribers in Pharmacy Daily's issue from 26 Jun 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Jun 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.